194 related articles for article (PubMed ID: 26747775)
1. Primed Mycobacterial Uveitis (PMU): Histologic and Cytokine Characterization of a Model of Uveitis in Rats.
Pepple KL; Rotkis L; Van Grol J; Wilson L; Sandt A; Lam DL; Carlson E; Van Gelder RN
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8438-48. PubMed ID: 26747775
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Aqueous and Vitreous Lymphocyte Populations From Two Rat Models of Experimental Uveitis.
Pepple KL; Wilson L; Van Gelder RN
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2504-2511. PubMed ID: 29847657
[TBL] [Abstract][Full Text] [Related]
3. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
Crane IJ; McKillop-Smith S; Wallace CA; Lamont GR; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1547-52. PubMed ID: 11381059
[TBL] [Abstract][Full Text] [Related]
4. Comparative Proteomic Analysis of Two Uveitis Models in Lewis Rats.
Pepple KL; Rotkis L; Wilson L; Sandt A; Van Gelder RN
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8449-56. PubMed ID: 26747776
[TBL] [Abstract][Full Text] [Related]
5. Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis.
John S; Bell OH; Wilson L; Copland DA; Pepple KL
J Vis Exp; 2021 Dec; (178):. PubMed ID: 34978282
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.
Miyazaki A; Kitaichi N; Ohgami K; Iwata D; Jin XH; Iwabuchi K; Morohashi T; Ohno S; Onoé K
Graefes Arch Clin Exp Ophthalmol; 2008 May; 246(5):747-57. PubMed ID: 18087711
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y
J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006
[TBL] [Abstract][Full Text] [Related]
8. Subretinal Transplantation of Human Amniotic Epithelial Cells in the Treatment of Autoimmune Uveitis in Rats.
Li J; Qiu C; Zhang Z; Yuan W; Ge Z; Tan B; Yang P; Liu J; Zhu X; Qiu C; Lai D; Guo L; Yu L
Cell Transplant; 2018 Oct; 27(10):1504-1514. PubMed ID: 30168350
[TBL] [Abstract][Full Text] [Related]
9. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
[TBL] [Abstract][Full Text] [Related]
10. A cell-permeable peptide inhibitor of p55PIK signaling alleviates ocular inflammation in mouse models of uveitis.
Zhu M; Yang H; Chen Z; Xia X; Deng Q; Shen Y
Exp Eye Res; 2020 Oct; 199():108180. PubMed ID: 32777209
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in retina during development of experimental autoimmune uveoretinitis in rats.
Watanabe T; Keino H; Kudo A; Sato Y; Okada AA
Br J Ophthalmol; 2016 Mar; 100(3):425-31. PubMed ID: 26541434
[TBL] [Abstract][Full Text] [Related]
12. A new small molecule for treating inflammation and chorioretinal neovascularization in relapsing-remitting and chronic experimental autoimmune uveitis.
Diedrichs-Möhring M; Leban J; Strobl S; Obermayr F; Wildner G
Invest Ophthalmol Vis Sci; 2014 Dec; 56(2):1147-57. PubMed ID: 25515581
[TBL] [Abstract][Full Text] [Related]
13. High mobility group box protein-1 in experimental autoimmune uveoretinitis.
Watanabe T; Keino H; Sato Y; Kudo A; Kawakami H; Okada AA
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394
[TBL] [Abstract][Full Text] [Related]
14. Intraocular DHODH-inhibitor PP-001 suppresses relapsing experimental uveitis and cytokine production of human lymphocytes, but not of RPE cells.
Diedrichs-Möhring M; Niesik S; Priglinger CS; Thurau SR; Obermayr F; Sperl S; Wildner G
J Neuroinflammation; 2018 Feb; 15(1):54. PubMed ID: 29467002
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
[TBL] [Abstract][Full Text] [Related]
16. A promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitis.
Adamus G; Karren LJ; Mooney J; Burrows GG
Ophthalmic Res; 2010; 44(1):24-33. PubMed ID: 20145422
[TBL] [Abstract][Full Text] [Related]
17. Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand.
Pepple KL; Wilson L; Van Gelder RN; Kovaleva M; Ubah OC; Steven J; Barelle CJ; Porter A
Transl Vis Sci Technol; 2019 Sep; 8(5):11. PubMed ID: 31588375
[TBL] [Abstract][Full Text] [Related]
18. [Expression of suppressor of cytokine signaling in retina of experimental autoimmune uveoretinitis].
Wang H; Zhou ZC; Peng XY; Zhao M
Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):876-82. PubMed ID: 19176113
[TBL] [Abstract][Full Text] [Related]
19. The effects of intraocular injection of interleukin-13 on endotoxin-induced uveitis in rats.
Lemaitre C; Thillaye-Goldenberg B; Naud MC; de Kozak Y
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2022-30. PubMed ID: 11481267
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of intraocular IFN-γ, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis.
Kaufmann U; Diedrichs-Möhring M; Wildner G
PLoS One; 2012; 7(11):e49008. PubMed ID: 23155443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
